0 NASDAQ Companies - March 6, 2019Zealand Pharma doses first patient in Phase 3 trial with dasiglucagon for the treatment of congenital hyperinsulinismRead More
0 NASDAQ Companies - March 6, 2019Nasdaq and Bourse Régionale des Valeurs Mobilières (BRVM) Sign New Market Surveillance Technology AgreementRead More
0 TSX News - March 6, 2019TransGlobe Energy Corporation Announces Release Date of Year-End and Fourth Quarter 2018 Results and Conference CallRead More
0 NASDAQ Companies - March 6, 2019ERYTECH to Host Fourth Quarter and Full Year 2018 Conference Call and Business UpdateRead More
0 TSX News - March 5, 2019Timbercreek Financial Announces 2018 Fourth Quarter Results and Year-End 2018 ResultsRead More
0 NASDAQ Companies - March 5, 2019Ascendis Pharma A/S Announces Pricing of Public Offering of ADSsRead More
0 NASDAQ Companies - March 5, 2019Sarepta Therapeutics Announces Pricing of $375.0 Million Public Offering of Common StockRead More
0 NYSE Companies - March 5, 2019Exantas Capital Corp. Reports Results for Three Months and Year Ended December 31, 2018Read More
0 NYSE Companies - March 5, 2019Grupo Aeroportuario del Pacifico Reports Passenger Traffic Increase of 4.9% for the Month of FebruaryRead More
